These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 38844295

  • 1. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Vivarelli M, Barratt J, Beck LH, Fakhouri F, Gale DP, Goicoechea de Jorge E, Mosca M, Noris M, Pickering MC, Susztak K, Thurman JM, Cheung M, King JM, Jadoul M, Winkelmayer WC, Smith RJH, for Conference Participants.
    Kidney Int; 2024 Sep; 106(3):369-391. PubMed ID: 38844295
    [Abstract] [Full Text] [Related]

  • 2. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Frémeaux-Bacchi V, Kavanagh D, Nester CM, Noris M, Pickering MC, Rodríguez de Córdoba S, Roumenina LT, Sethi S, Smith RJ, Conference Participants.
    Kidney Int; 2017 Mar; 91(3):539-551. PubMed ID: 27989322
    [Abstract] [Full Text] [Related]

  • 3. Complement in glomerular diseases.
    Tan Y, Zhao MH.
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():11-15. PubMed ID: 30298653
    [Abstract] [Full Text] [Related]

  • 4. Complement and Complement Targeting Therapies in Glomerular Diseases.
    Andrighetto S, Leventhal J, Zaza G, Cravedi P.
    Int J Mol Sci; 2019 Dec 16; 20(24):. PubMed ID: 31888179
    [Abstract] [Full Text] [Related]

  • 5. Complement and glomerular disease: new insights.
    Pickering M, Cook HT.
    Curr Opin Nephrol Hypertens; 2011 May 16; 20(3):271-7. PubMed ID: 21422921
    [Abstract] [Full Text] [Related]

  • 6. Complement and the Kidney: An Overview.
    Thurman JM.
    Adv Chronic Kidney Dis; 2020 Mar 16; 27(2):86-94. PubMed ID: 32553250
    [Abstract] [Full Text] [Related]

  • 7. Complement and kidney disease.
    Cook HT.
    Curr Opin Nephrol Hypertens; 2013 May 16; 22(3):295-301. PubMed ID: 23508058
    [Abstract] [Full Text] [Related]

  • 8. Complement-mediated kidney diseases.
    Poppelaars F, Thurman JM.
    Mol Immunol; 2020 Dec 16; 128():175-187. PubMed ID: 33137606
    [Abstract] [Full Text] [Related]

  • 9. Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015.
    Noris M, Remuzzi G.
    Am J Kidney Dis; 2015 Aug 16; 66(2):359-75. PubMed ID: 26032627
    [No Abstract] [Full Text] [Related]

  • 10. Complement Inhibitors in Clinical Trials for Glomerular Diseases.
    Zipfel PF, Wiech T, Rudnick R, Afonso S, Person F, Skerka C.
    Front Immunol; 2019 Aug 16; 10():2166. PubMed ID: 31611870
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
    Anliker-Ort M, Dingemanse J, van den Anker J, Kaufmann P.
    Front Immunol; 2020 Aug 16; 11():599417. PubMed ID: 33362783
    [Abstract] [Full Text] [Related]

  • 13. Complement and glomerular diseases.
    Popat RJ, Robson MG.
    Nephron Clin Pract; 2014 Aug 16; 128(3-4):238-42. PubMed ID: 25412932
    [Abstract] [Full Text] [Related]

  • 14. All Things Complement.
    Thurman JM, Nester CM.
    Clin J Am Soc Nephrol; 2016 Oct 07; 11(10):1856-1866. PubMed ID: 27340286
    [Abstract] [Full Text] [Related]

  • 15. C3 glomerulopathy and atypical hemolytic uremic syndrome: an updated review of the literature on alternative complement pathway disorders.
    Turkmen K, Baloglu I, Ozer H.
    Int Urol Nephrol; 2021 Oct 07; 53(10):2067-2080. PubMed ID: 33389509
    [Abstract] [Full Text] [Related]

  • 16. Novel roles of complement in renal diseases and their therapeutic consequences.
    Wada T, Nangaku M.
    Kidney Int; 2013 Sep 07; 84(3):441-50. PubMed ID: 23615508
    [Abstract] [Full Text] [Related]

  • 17. Urinary complement biomarkers in immune-mediated kidney diseases.
    Kesarwani V, Bukhari MH, Kahlenberg JM, Wang S.
    Front Immunol; 2024 Sep 07; 15():1357869. PubMed ID: 38895123
    [Abstract] [Full Text] [Related]

  • 18. Complement inhibitors for kidney disease.
    Wooden B, Tarragon B, Navarro-Torres M, Bomback AS.
    Nephrol Dial Transplant; 2023 Nov 08; 38(Supplement_2):ii29-ii39. PubMed ID: 37218685
    [Abstract] [Full Text] [Related]

  • 19. Targeting the complement cascade: novel treatments coming down the pike.
    Thurman JM, Le Quintrec M.
    Kidney Int; 2016 Oct 08; 90(4):746-52. PubMed ID: 27325183
    [Abstract] [Full Text] [Related]

  • 20. Molecules Great and Small: The Complement System.
    Mathern DR, Heeger PS.
    Clin J Am Soc Nephrol; 2015 Sep 04; 10(9):1636-50. PubMed ID: 25568220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.